阿托伐他汀联合窄谱中波紫外线治疗成人活动期白癜风的随机临床试验。
Atorvastatin in Combination With Narrowband UV-B in Adult Patients With Active Vitiligo: A Randomized Clinical Trial.
机构信息
Department of Dermatology, Université Côte d'Azur, Centre Hospitalier Universitaire Nice, Nice, France.
National Skin Centre, Singapore.
出版信息
JAMA Dermatol. 2018 Jun 1;154(6):725-726. doi: 10.1001/jamadermatol.2017.6401.
Abstract
This randomized clinical trial evaluates the use of atorvastatin combined with narrowband UV-B therapy vs narrowband UV-B therapy alone in adult patients with active vitiligo.
摘要
这项随机临床试验评估了阿托伐他汀联合窄谱 UV-B 治疗与单独窄谱 UV-B 治疗在活动期白癜风成年患者中的应用。
相似文献
1
Atorvastatin in Combination With Narrowband UV-B in Adult Patients With Active Vitiligo: A Randomized Clinical Trial.阿托伐他汀联合窄谱中波紫外线治疗成人活动期白癜风的随机临床试验。
JAMA Dermatol. 2018 Jun 1;154(6):725-726. doi: 10.1001/jamadermatol.2017.6401.
2
Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.阿法诺肽与窄谱中波紫外线光疗治疗白癜风：一项随机多中心试验。
JAMA Dermatol. 2015 Jan;151(1):42-50. doi: 10.1001/jamadermatol.2014.1875.
3
A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.一项随机、双盲、安慰剂对照的假性过氧化氢酶乳膏联合窄谱中波紫外线治疗白癜风的临床试验。
Br J Dermatol. 2009 Oct;161(4):910-7. doi: 10.1111/j.1365-2133.2009.09252.x. Epub 2009 Jun 11.
4
Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.四氢姜黄素乳膏联合靶向窄谱中波紫外线光疗治疗白癜风：一项初步随机对照研究。
Photomed Laser Surg. 2010 Oct;28(5):679-84. doi: 10.1089/pho.2009.2637.
5
A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.一项关于2%托法替布乳膏联合窄谱中波紫外线治疗面部白癜风的初步研究。
J Am Acad Dermatol. 2019 Aug;81(2):646-648. doi: 10.1016/j.jaad.2019.04.032. Epub 2019 Apr 19.
6
Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.托法替布联合低剂量窄谱UV-B光疗实现白癜风的快速复色
JAMA Dermatol. 2018 Mar 1;154(3):370-371. doi: 10.1001/jamadermatol.2017.5778.
7
The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.1%吡美莫司乳膏联合窄谱中波紫外线治疗白癜风的疗效：一项双盲、安慰剂对照临床试验
J Dermatolog Treat. 2009;20(1):14-8. doi: 10.1080/09546630802155057.
8
Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.前期激光磨皮对窄谱中波紫外线联合强效外用皮质类固醇治疗抵抗性非节段性白癜风的疗效影响。
Br J Dermatol. 2012 Jan;166(1):208-11. doi: 10.1111/j.1365-2133.2011.10564.x. Epub 2011 Nov 17.
9
Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.10600nm 消融性分段二氧化碳激光联合窄谱中波紫外线治疗难治性非节段性白癜风：一项前瞻性、随机半体对照研究。
Br J Dermatol. 2012 Mar;166(3):658-61. doi: 10.1111/j.1365-2133.2011.10723.x. Epub 2012 Jan 19.
10
A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.一项随机、安慰剂对照、双盲试验，比较窄谱中波紫外线联合0.1%他克莫司软膏与窄谱中波紫外线联合安慰剂治疗泛发性白癜风的疗效。
Arch Dermatol. 2006 Jul;142(7):927-9. doi: 10.1001/archderm.142.7.927.
引用本文的文献
1
The association between metabolic syndrome and vitiligo: a systematic review.代谢综合征与白癜风之间的关联：一项系统综述。
Postepy Dermatol Alergol. 2025 Apr 15;42(2):134-142. doi: 10.5114/ada.2025.149438. eCollection 2025 Apr.
2
Emerging Therapeutic Innovations for Vitiligo Treatment.白癜风治疗的新兴治疗创新
Curr Issues Mol Biol. 2025 Mar 14;47(3):191. doi: 10.3390/cimb47030191.
3
Vitiligo: From mechanisms of disease to treatable pathways.白癜风：从发病机制到可治疗途径
Skin Health Dis. 2024 Sep 30;4(6):e460. doi: 10.1002/ski2.460. eCollection 2024 Dec.
4
Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis.内质网功能障碍：白癜风发病机制的新机制
Clin Cosmet Investig Dermatol. 2024 May 17;17:1133-1144. doi: 10.2147/CCID.S459070. eCollection 2024.
5
Role of non‑coding RNAs in UV‑induced radiation effects (Review).非编码RNA在紫外线诱导的辐射效应中的作用（综述）
Exp Ther Med. 2024 Apr 23;27(6):262. doi: 10.3892/etm.2024.12550. eCollection 2024 Jun.
6
Spontaneous immunological activities in the target tissue of vitiligo-prone Smyth and vitiligo-susceptible Brown lines of chicken.白癜风易感鸡 Smyth 系和白癜风不易感鸡 Brown 系靶组织中的自发免疫活性。
Front Immunol. 2024 Apr 24;15:1386727. doi: 10.3389/fimmu.2024.1386727. eCollection 2024.
7
Implementation of the vitiligo area scoring index in clinical studies of patients with vitiligo: a scoping review.白癜风面积评分指数在白癜风患者临床研究中的应用：一项范围综述。
Arch Dermatol Res. 2023 Oct;315(8):2233-2259. doi: 10.1007/s00403-023-02608-3. Epub 2023 Apr 7.
8
Vitiligo: What's old, what's new.白癜风：旧貌与新颜
Dermatol Reports. 2021 Sep 15;13(2):9142. doi: 10.4081/dr.2021.9142. eCollection 2021 Aug 1.
9
Updates and new medical treatments for vitiligo (Review).白癜风的最新进展及新的医学治疗方法（综述）
Exp Ther Med. 2021 Aug;22(2):797. doi: 10.3892/etm.2021.10229. Epub 2021 May 25.
10
Vitiligo, From Physiopathology to Emerging Treatments: A Review.白癜风，从病理生理学到新兴治疗方法：综述
Dermatol Ther (Heidelb). 2020 Dec;10(6):1185-1198. doi: 10.1007/s13555-020-00447-y. Epub 2020 Sep 19.
本文引用的文献
1
Simvastatin Protects Human Melanocytes from HO-Induced Oxidative Stress by Activating Nrf2.辛伐他汀通过激活Nrf2保护人黑素细胞免受HO诱导的氧化应激。
J Invest Dermatol. 2017 Jun;137(6):1286-1296. doi: 10.1016/j.jid.2017.01.020. Epub 2017 Feb 4.
2
A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.一项双盲、安慰剂对照的II期临床试验，旨在评估口服辛伐他汀治疗白癜风的效果。
J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015.
3
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.辛伐他汀可预防并逆转白癜风小鼠模型中的色素脱失。
J Invest Dermatol. 2015 Apr;135(4):1080-1088. doi: 10.1038/jid.2014.529. Epub 2014 Dec 18.
4
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.CXCL10 对于白癜风小鼠模型中色素脱失的进展和维持至关重要。
Sci Transl Med. 2014 Feb 12;6(223):223ra23. doi: 10.1126/scitranslmed.3007811.
5
Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.阿托伐他汀可降低克罗恩病患者血浆趋化因子（CXCL10）水平。
PLoS One. 2009;4(5):e5263. doi: 10.1371/journal.pone.0005263. Epub 2009 May 6.
Zotero 插件